Helical membrane proteins are typically assumed to attain stable transmembrane topologies immediately upon co-translational membrane insertion. Here we show that unassembled monomers of the small multidrug resistance (SMR) family exist in a dynamic equilibrium where the N-terminal transmembrane helix flips in and out of the membrane, with rates that depend on dimerization and the polypeptide sequence. Thus, membrane topology can display rapid dynamics in vivo and can be regulated by post-translational assembly.
reaction with 4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic acid (AMS), a reagent that cannot cross the inner bacterial membrane. The level of cysteine blocking by AMS, quantified by a gelshift assay ( Supplementary Fig. 2 ), thus reports on the periplasmic accessibility of the engineered cysteine 12, 19 . The accessibility data agreed almost perfectly with the expected topology, with the cysteines alternating between nearly full blocking or inaccessibility from the periplasm in the single-topology mutants, while showing partial access in the dual-topology wild-type protein (Fig. 1c) . Unexpectedly, however, the EmrE(N in /C in -P3C) mutant showed ∼65% periplasmic blocking, despite the expected cytosolic location of the N terminus. Control experiments confirmed that EmrE(N in / C in -P3C) does not form intermolecular disulfides ( Supplementary  Fig. 3 ). A fraction of the EmrE(N in /C in -P3C) molecules thus has the N-terminal tail localized in the periplasm, indicating that TMH1 may be able to flip in and out of the membrane.
We next followed the post-translational kinetics of periplasmic blocking of the N terminus in EmrE(N in /C in -P3C). Expression of EmrE radiolabeled by a pulse of [ 35 S]Met was chased for 5 min with excess cold methionine, ensuring that all radiolabeled EmrE had been fully synthesized several minutes before the AMS treatment ( Supplementary Fig. 4 ). Control experiments indicated that the reaction of AMS with a periplasmic cysteine is completed within 2.5 min, while a cytosolic cysteine remains mostly unblocked by AMS over time ( Supplementary Fig. 5 ). The N-terminal cysteine in EmrE(N in /C in -P3C) showed a remarkably different behavior, with 30% being blocked quickly and the remaining 70% gradually getting blocked by AMS over 40 min (Fig. 1d ). By contrast, confining the N terminus to the cytoplasm by adding two N-terminal arginines 11 prevented periplasmic access ( Supplementary Fig. 7) .
The data can be fit by a simple kinetic model ( Fig. 1e ), in which TMH1 equilibrates between an inserted, transmembrane state and a periplasmically exposed, uninserted state. In the uninserted state, the N-terminal cysteine gets immediately and irreversibly modified by AMS, until all molecules react. To confirm that an equilibrium exists between inserted and uninserted TMH1, EmrE(N in /C in -P3C) was incubated for 40 min before AMS blocking. This did not affect the blocking kinetics, consistent with a pre-established equilibrium ( Supplementary Fig. 8a ). The blocking kinetics was independent of AMS concentration ( Supplementary Fig. 8b) , showing that the overall reaction is dominated by the rate-limiting transition from the inserted to the uninserted state (k 1 ). The fit yields a half-life of ~10 min for the transmembrane state (k 1 = 1.1 ± 0.2 × 10 −3 s −1 ) and suggests that at equilibrium, ~31% of the molecules have their N terminus in the periplasm, enabling their immediate blocking upon addition of AMS. We estimate a half-life of ~3 min for the reverse transition from the uninserted to the inserted state. TMH1 of monomeric EmrE is therefore not efficiently integrated into the
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Notably, the topologically dynamic EmrE(N in /C in -P3C) does not have any oppositely oriented subunits to interact with and remains monomeric. In the crystal structure of the EmrE dimer 15 , TMH1 interacts extensively with helices of the same subunit ( Fig. 2a ). The dynamics of TMH1 therefore suggest that the monomer is not stably folded before dimerization. Upon folding however, TMH1 should presumably get fixed in the membrane. Indeed, reconstituting the functional dimer by co-expressing the oppositely oriented N out /C out mutant abolished the topological dynamics, stabilizing the N terminus in the cytosol (Fig. 2b) .
We next asked if the dynamic topology of TMH1 is also common to other SMR proteins. We examined two distant EmrE homologs (sharing only 15-30% sequence identity) that belong to the heterodimeric branch of the SMR family, B8J442 from Desulfovibrio desulfuricans and Q1MPU8 from Lawsonia intracellularis (names given are Uniprot accessions). Both proteins have a N in /C in topology and can dimerize with an N out /C out partner encoded by a separate gene in their operons 12 . We introduced a reporter cysteine in 
. Representative gels are shown in Supplementary Fig. 6a . e, Kinetic model for periplasmic blocking of EmrE(N in /C in -P3C). TMH1 equilibrates between an integrated, transmembrane state and a periplasmically accessible state. The latter is quickly and irreversibly blocked by periplasmic AMS. TMH1 is depicted as interacting with the membrane surface, although the detailed interaction remains to be studied. Supplementary Fig. 6b ,c.
the cytosolic N or C termini of both proteins and followed their periplasmic blocking by AMS over time. Both the N and C termini of Q1MPU8 displayed very slow dynamics ( Fig. 2c and Supplementary  Fig. 9 ). The long timescales required for detecting such slow events enhance background and compromise the signal-to-noise ratio. However, in both cases, co-expressing the partner appeared to stabilize the cytosolic localization. The B8J442 homolog behaved very differently. Here the dynamics of the N terminus were so rapid that the cysteine was predominantly blocked already at the 1 min time point ( Fig. 2d ). Dimerization with the partner dramatically stabilized the N terminus in the cytosol. By contrast, the C terminus did not show appreciable dynamics even when expressed alone. Thus, while topological dynamics in SMR monomers vary greatly, dimerization always helps stabilize the fully integrated state. The rates of the topological dynamics in EmrE and its homologs seemed to correlate inversely with the length of their hydrophilic N-terminal tails ( Fig. 2b-d) , supporting the idea that dynamics are slowed by the unfavorable transfer of hydrophilic tail regions across the hydrophobic membrane 10, 18 . To test this, we extended the N terminus of EmrE(N in /C in -P3C) by one, two or three serines. The hydrophilic extensions gradually slowed the periplasmic blocking reaction, nearly completely abolishing it at two serines ( Fig. 2e ). Making the membrane-embedded part of TMH1 more hydrophobic also slowed the dynamics, while hydrophilic mutations had the opposite effect (Fig. 2f ). Strikingly, ln(k 1 ) was found to be directly proportional to the hydrophobicity of TMH1 (ref. 20 ) ( Supplementary Fig. 10 ). This suggests that the activation energy for the topological transition scales with the hydrophilicity of the N-terminal tail and the hydrophobicity of the TMH.
We were surprised to find even the most hydrophilic TMH1 mutants well inserted at t = 0 ( Fig. 2f) . To follow the insertion status of TMH1 over time, cells were pulsed with [ 35 S]Met and chased with non-radioactive methionine, to allow the protein to age. At different chase times we then used a brief AMS blocking to probe the fraction periplasmic N terminus. After 2 min of chase, all mutants were well inserted, with ~20% periplasmic accessibility ( Supplementary Fig. 11a ). The hydrophobic G9L mutant remained well inserted over time, while the hydrophilic mutants (I16T and L12T) equilibrated to the majority of the molecules having a periplasmically located N terminus. A similar experiment showed that halting of the dynamics by two N-terminal serines caused TMH1 to remain stuck in its initial, well-inserted state ( Supplementary  Fig. 11b ), similar to a control with two arginines 11 . Therefore, the energetics of the initial co-translational insertion seems to favor insertion and is likely dictated by equilibration of TMH1 between the somewhat polar translocon channel and the surrounding membrane 20 . Once free of the translocon, TMH1 may then re-equilibrate between the transmembrane and periplasmically exposed states, unless a flanking hydrophilic tail traps it in the initial, membraneintegrated state.
The short and not very polar N-terminal tail and the relatively weak hydrophobicity of EmrE TMH1 are not unusual among other TMHs in the Escherichia coli inner-membrane proteome (Fig. 3a,b ), but the combination of these two features makes EmrE TMH1 stand out (Fig. 3c) . Nevertheless, the data in Fig. 3c suggest that dozens of TMHs, if not more, in other E. coli membrane proteins are likely to have a dynamic topology, at least before they fold.
The two-stage model of membrane protein folding, which separates the TMH insertion step from the subsequent folding step, was proposed in 1990 and still remains a central tenet in membraneprotein research [21] [22] [23] . EmrE deviates from this model, with stable membrane integration of TMH1 being coupled to a post-translational folding and dimerization step. Our findings have implications for the theory of membrane-protein insertion and folding 18, 22, 24 , and for membrane-protein quality control 25 .
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Methods
Reagents. All reagents were from Sigma unless otherwise noted.
Bacterial strains. E. coli DH5α was used for plasmid propagation. For most protein-expression experiments, E. coli BL21 (DE3) ΔemrE::kana R , ΔmdtJI::Cm R (ref. 12 ) with deletion of the emrE gene and the mdtJI operon was used to avoid potential interactions between expressed proteins and chromosomally encoded SMR transporters. E. coli BL21 (DE3) ΔdsbA::kana R was generated by P1 transduction of the resistance allele ΔdsbA::kana R from the Keio collection 26 into BL21 (DE3) as described 27 .
Plasmids. All proteins used were versions of the original proteins that lacked cysteine. EmrE was expressed from a pET-Duet-1 vector as described 12 , typically from the second multiple cloning site. The EmrE N in /C in and N out /C out mutants had the following substitutions, respectively: R29G, R82G and S107K; and T28R, L85R and R106A 16 . When two EmrE variants were co-expressed, the N out /C out mutant lacking cysteine was expressed in excess from multiple cloning site 1, which supports higher expression. The heterodimeric SMR transporters operons were expressed from pET19b (Novagen) as described 12 . The cysteine substitutions are S8C and N125C for the N and C termini of Q1MPU8, respectively, and S3C and E102C for the N and C termini of B8J442, respectively.
Cell growth and specific radiolabeling of tag-less SMR proteins. Experiments were carried out as described 12, 28 . In brief, BL21 (DE3) ΔemrE::kana R ΔmdtJI::Cm R harboring plasmids encoding the proteins of interest were grown in M9 minimal medium at 37 °C to mid-log phase (OD 600 of ~0.5). The cultures were then induced with 0.1 mM IPTG for 10 min, followed by 15 min incubation with 0.2 mg ml −1 rifampicin, with shaking at 37 °C. Proteins were labeled with 15 μCi [ 35 S]Met, typically for 5 min, then mixed with a high excess (2 mM) of non-radioactive methionine for variable chase times and put on ice for 5 min to stop the reaction. The chase was typically 5 min, except for Fig. 1c and Supplementary Figs. 3 and 2 , for which the chase time was 0 min (that is, the samples were put directly on ice after mixing with non-radioactive methionine).
Cysteine blocking in whole cells. The protocol was adapted from Fluman et al 12 .
Radiolabeled cells (typically from a 10-ml culture for a kinetic profile) were washed by centrifugation at 4 °C, 3,200g for 5 min and resuspension in 4 ml of Na-Mg buffer (150 mM NaCl, 30 mM Tris-HCl, pH 7.5, 5 mM MgSO 4 and 1 mM Tris(2carboxyethyl)phosphine (TCEP)). Cells were pelleted again and resuspended in 1 ml Na-Mg buffer and divided into three microcentrifuge tubes, containing 550, 110 or 220 µl, for blocking with AMS (Setareh Biotech), NEM or water, respectively. Before each cysteine-blocking procedure, the respective culture was allowed to equilibrate to 30 °C for 4 min. At t = 0, the sulfhydryl reagents were added (dissolved freshly, typically the AMS tube received 55 µl of 100 mM AMS, the NEM tube received 22 µl of 0.2 M NEM and the water tube received 22 µl of water). The cells were allowed to react for variable times at 30 °C with gentle mixing, before quenching by mixing 100 µl of cells with prechilled tubes containing 0.5 ml of Na-Mg buffer supplemented with 20 mM DTT. Cells were allowed to quench on ice for at least 20 min. Typically five time points with AMS were taken with one and two early range time points with NEM and water, respectively, as controls. Samples were washed by centrifugation at 4 °C, 10,000g for 2 min and resuspended in 0.9 ml of Na-Mg buffer. The cells were then pelleted again and resuspended in 150 µl of lysozyme buffer (150 mM NaCl, 30 mM Tris-HCl, pH 8, 10 mM EDTA, 1 mM TCEP, complete protease inhibitor (Roche) and 1 mg ml −1 lysozyme) and frozen in −20 °C for at least 20 min. Cells were then lysed and the remaining unblocked cysteines were PEGylated.
Cell lysis and cysteine PEGylation. Cells were disrupted by thawing at 25 °C for 5 min followed by shaking at 37 °C for 10 min. Then, 0.9 ml of DNase solution (15 mM MgSO 4 , 10 µg ml −1 DNase I, 1 mM TCEP and 0.5 mM phenylmethanesulfonyl fluoride) was added and the samples were allowed to shake at 37 °C for 10 min before transferring them to ice. Crude membranes were collected by centrifugation at 4 °C, 20,000g for 20 min and the pellet was resuspended in 50 µl of Na buffer (150 mM NaCl, 30 mM Tris-HCl, pH 7.5 and 1 mM TCEP). Membrane proteins were solubilized and PEGylated by adding 7 µl of 10% β-d-dodecyl maltoside (Anatrace) and 13 µl of 27 mM methoxypolyethylene glycol maleimide (typically 5 kDa from Sigma, or 2 kDa from Nanocs for protein Q1MPU8). The samples were incubated with continuous mixing at 30 °C for 1 h and the reaction was quenched by mixing with 17.5 µl of 5× sample buffer (120 mM Tris-HCl, pH 6.8, 50% glycerol, 100 mM DTT, 2% SDS and 0.1% bromophenol blue). Samples were resolved on 15% SDS-PAGE gels run with a modified running buffer containing only 0.05% SDS 29 . Gels were dried, visualized by autoradiography and quantified.
Following N-terminal insertion status as the protein ages. BL21(DE3) ΔemrE::kana R ΔmdtJI::Cm R harboring plasmids encoding the proteins of interest were grown in M9 minimal medium at 37 °C as above. Following 15 min rifampicin treatment, a 7-ml culture was pulsed with 15 μCi [ 35 S]Met and 1 mM TCEP for 1 min while shaking at 37 °C. The culture was then chased by mixing with a high excess (2 mM) of non-radioactive methionine for variable chase times. At the end of the chase, cysteines were blocked by mixing 0.5-ml culture aliquots for 2 min at 37 °C with 25 µl of 100 mM AMS or 0.2 M NEM or water as controls. The reagents were then quenched by adding 25 µl of 1 M DTT, mixing for 30 s at 37 °C and then transferring to ice for at least 10 min. Samples were washed by centrifugation at 1 nature research | reporting summary Last updated by author(s): Jul 16, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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